The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.

The secondary objectives of the study are:

* To assess the long-term efficacy of dupilumab in pediatric participants with AD
* To assess the trough concentrations of functional dupilumab in serum and the immunogenicity in pediatric participants with AD after re-treatment with dupilumab

Optional Pre-filled Pen (PFP) Sub-Study in pediatric patients ≥2 to \<12 years of age with AD

Co-Primary Objectives are:

* To evaluate the pharmacokinetic (PK) of dupilumab PFPs
* To evaluate the safety of dupilumab PFPs

Secondary Objective is:

- To evaluate the immunogenicity of dupilumab PFPs

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Regeneron Pharmaceuticals

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

SLUCare Academic Pavilion - Endocrinology Division Research

West Lafayette, Indiana

Indianapolis, IN

Dermatology and Skin Cancer Center Leawood

North Little Rock

Hot Springs, AR

Lincoln, NE

Bexley, OH

Troy, MI

Windsor, Canada

Oklahoma City, OK

Derm Center

Plano, TX

Dallas, TX

Charlotte, NC

Waterloo, Canada

Hamilton, Canada

Burlington, Canada

Oakvile, Canada

Mississauga, Canada

Etobicoke, Canada

Niagara Falls, Canada

Toronto, Canada

Ontario, Canada

Richmond Hill, CA

Richmond Hill, Canada

Newmarket, Canada

Ontario, CA

Texas Medical Center

Ajax, Canada

McGovern Medical School - ACTAT - Research Department

Bellaire, TX

Chevy Chase, MD

Camp Hill, PA

Towson, MD

Internal Medicine Glennan Center for Geriatrics and Gerontology

Rapid City, SD

San Antonio, Texas

San Antonio, TX

Department of Cardiology

New York, NY

Ottawa, Canada

Jose Garcia, Coordinator

Forest Hills Dermatology Group

Albuquerque, NM

Clinical Operations Department

Boca Raton, FL

Miami Lakes, FL

Hialeah, FL

Miami, FL

Coral Gables, FL

Saskatoon, Canada

Scottsdale, AZ

Las Vegas, NV

Boise, ID

Research Center

Calgary, Canada

Edmonton, Canada

Vida Dermatology South

Reno - Moana Lane Location

Long Beach, CA

Los Angeles, CA

Northridge, CA

Santa Monica, CA

Bakersfield, CA

Canoga Park, California

Kelowna, Canada

Sacramento, CA

Dublin, CA

Portland, OR

Clinical Research Institute of Southern Oregon (CRISOR)

St. Johns, NL

San Juan, PR

Maldegem, Belgium

Kortrijk, Belgium

Clinical Research Unit

Remscheid, Germany

Hannover, Germany

Leipzig, Germany

Haematology Department

Tartu, Estonia

Clinical Trial Center

Lublin, Poland

Szolnok, Hungary

Santiago, Chile

Rosario, Argentina

Buenos Aires, Argentina

Nagoya City University Hospital

Benowa, Australia

Carlton, Australia

Amgen

Find clinical trials for Eczema in St Louis, MO

Related conditions:

Eczema trials near St Louis, MO, USA:

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

Find clinical trials for Eczema in .css-epvm6{white-space:nowrap;}St Louis, MO

Related conditions:

Eczema trials near St Louis, MO, USA:

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

Find clinical trials for Eczema in St Louis, MO